TrialBlood2020
A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis.
Murielle Roussel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
59 papers cite it
this papertrialcites it
TrialBlood2020
Murielle Roussel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.